Status:
UNKNOWN
Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial
Lead Sponsor:
Samsung Medical Center
Conditions:
Delayed Bleeding
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
after endoscopic submucosal dissection(ESD) of early gastric cancer, conventional proton pump(PPI) inhibitors and H2 receptor antagonists have a controversial effect on preventing bleeding from artifi...
Eligibility Criteria
Inclusion
- the patients who agreed informed consent
- gastric adenoma or early gastric cancer which is eligible for conventional ESD indication
Exclusion
- recent drug history of PPI, H2 rector antagonist, bismuth and antibiotics within 4 weeks
- recent drug history of anticoagulant or antiplatelet agent within 7 days
- s/p subtotal gastrectomy
- recurred gastric adenoma or cancer
- pregnant or breast feeding patients
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT01179724
Start Date
July 1 2009
End Date
September 1 2010
Last Update
August 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 82